Drugs of abuse and HIV - A perspective

Journal of Neuroimmunology

Volumn 147, Issue 1-2, 2004, Pages 9-12

  Ansari, Aftab Ahmed ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disease cofactors; Disease progression; Drugs of abuse; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT; ILLICIT DRUG;

ADDICTION; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG ABUSE; HEART DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; KIDNEY DISEASE; LUNG DISEASE; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; VIROLOGY;

EID: 1642534290     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.006     Document Type: Conference Paper

References (34)

1. Ansari A.A., Onlamoon N., Bostik P., Mayne A.E., Gargano L., Pattanapanyasat K. Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys. Front. Biosci. 8:2003;1030-1050.
2. Arens M. Clinically relevant sequence based genotyping of HBV, HCV, CMV, and HIV. J. Clin. Virol. 22:2001;11-29.
3. Avila A.H., Morgan C.A., Bayer B.M. Stress-induced suppression of the immune system after withdrawal from chronic cocaine. J. Pharmacol. Exp. Ther. 305:2003;290-297.
4. Chang S.L., Wu G.D., Patel N.A., Vidal E.L., Fiala M. The effects of interaction between morphine and interleukin-1 on the immune response. Adv. Exp. Med. Biol. 437:1998;67-72.
5. Des Jarlais D.C., Frieman S.R. Gender differences in response to HIV infection. Adv. Biochem. Psychopharmacol. 44:1988;159-163.
6. Di Martino V., Rufat P., Boyer N., Renard P., Degos F., Martinot-Peignoux M., Matheron S., Le Moing V., Vachon F., Degott C., Valla D., Marcellin P. The influence of human immunodeficiency virus co-infection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 34:2001;193-199.
7. Donahoe R.M., Adler M.W. Substance abuse and the immune system. Drug Alcohol. Depend. 62:2001;109-110.
8. Eisenstein T.K., Hilburger M.E. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83:1998;36-44.
9. Friedman H., Klein T., Specter S., Pross S., Newton C., Blanchared D.K., Widen R. Drugs of abuse and virus susceptibility. Adv. Biochem. Psychopharmacol. 44:1988;125-137.
10. Glasel J.A. The effects of morphine on cell proliferation. Prog. Drug Res. 55:2000;33-80.
11. Goumon Y., Stefano G.B., Aunis D., Metz-Boutigue M.H. Implications of endogenous morphine in the communication between neuroendocrine and immune systems. Ann. N.Y. Acad. Sci. 971:2002;542-543.
12. Hall D.M., Suo J.L., Weber R.J. Opioid mediated effects on the immune system: sympathetic nervous system involvement. J. Neuroimmunol. 83:1998;29-35.
13. Hanna G.J. HIV-1 genotypic and phenotypic resistance. Clin. Lab. Med. 22:2002;637-649.
14. Hill A.V. The genomics and genetics of human infectious disease susceptibility. Ann. Rev. Genomics Hum. Genet. 2:2001;373-400.
15. Jensen M.A., Van't Wout A.B. Predicting HIV-1 co-receptor usage with sequence analysis. AIDS Rev. 5:2003;104-112.
16. Jiang J.D., Bekesi G.J. Antibody responses to HIV-1 antigens are higher in HIV-1 (+) intravenous drug users than in HIV-1 (+) homosexual. Biomed. Pharmacother. 55:2001;313-315.
17. Kimmel P.L., Barisoni L., Kopp J.B. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann. Intern. Med. 139:2003;214-226.
18. Madden J.J., Whaley W.L., Ketelsen D. Opiate binding sites in the cellular immune system: expression and regulation. J. Neuroimmunol. 83:1998;57-62.
19. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62:2001;111-123.
20. Mellon R.D., Bayer B.M. Evidence for central opioid receptors on the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J. Neuroimmunol. 83:1998;19-28.
21. Moroni M., Antinori S. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. AIDS. 17(Suppl. 1):2003;S51-S64.
22. Nyambi P.N., Nadas A., Mbah H.A., Burda S., Williams C., Gorny M.K., Zola-Pazner S. Immunoreactivity of intact virions of human immunodeficiency virus type I (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes. J. Virol. 74:2000;10670-10680.
23. Paris R., Sirisopona N., Benenson M., Amphaiphis R., Tuntichaivanich C., Myint K.S., Brown A.E. The association between hepatitis C virus and HIV-1 in preparatory cohorts for HIV vaccine trials in Thailand. AIDS. 17:2003;1363-1367.
24. Peterson P.K., Molitor P.W., Chao C.C. The opioid-cytokine connection. J. Neuroimmunol. 83:1998;63-69.
25. Roy S., Loh H.H. Effects of opioids on the immune system. Neurochem. Res. 21:1996;1375-1386.
26. Roy S., Balasubramanian, Sumandeep S., Charboneau R., Wang J., Melnyk D., Beilman G.J., Vatassery R., Barke R.A. Morphine directs T cells toward T (H2) differentiation. Surgery. 130:2001;305-309.
27. Sharp B.M., Roy S., Bidlack J.M. Evidence for opioid receptors on cells involved in host defense and the immune system. J. Neuroimmunol. 83:1998;45-56.
28. Singhal P.C., Sharma P., Kapasi A.A., Reddy K., Franki N., Gibbons N. Morphine enhances macrophage apoptosis. J. Immunol. 160:1998;1886-1893.
29. Strasfeld L.O.Y., Netski D., Thomas D.L., Klein R.S. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J. Acquir. Immune Defic. Syndr. 33:2003;356-364.
30. Sundstrom J.B., Mosunjac M., Martinson D.E., Bostik P., Donahoe R.M., Gravanis M.B., Ansari A.A. Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. AIDS Res. Hum. Retrovir. 17:2001;1605-1614.
31. Sundstrom J.B., Matinson D.E., Mosunjac M., Bostik P., McMullan L.K., Donahoe R.M., Gravanisd M.B., Ansari A.A. Norepinephrine enhances adhesion of HIV-1 infected leukocytes to cardiac microvascular endothelial cells. Exp. Biol. Med. 228:2003;730-740.
32. Turchan J., Anderson C., Hauser K.F., Sun Q., Zhang J., Liu Y., Wise P.M., Kruman I., Maragos W., Matson M.P., Booze R., Nath A. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2:2001;3-17.
33. Wang J., Barke R.A., Charboneau R., Loh H.H., Roy S. Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP dependent pathways. J. Biol. Chem. 278:2003;37622-37631.
34. Weiver N.J., Goodman J.W., Kimmel P.L. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int. 63:2003;1618-1631.